Niche Xerostomia Prisyna has a proven focus on dry mouth relief with Moisyn, indicating a potential entry point for sales conversations with dental practices, ENT specialists, and hospice or oncology patients where xerostomia is prevalent.

Glycomics Advantage Leveraging glycomics-based oral care offers a differentiator in the market, suggesting opportunities to partner with distributors or clinics seeking innovative mucosal health solutions and premium oral care products.

Clinical Heritage As the oral care division of Synedgen, Prisyna benefits from established research lineage, providing a credible platform for pilot programs, regulatory discussions, and evidence generation with potential customers.

Growing Footprint With a lean team and a recent product launches history since 2015, there is room to scale via channel partnerships, contract manufacturers, and direct-to-practice sales in dental and medical device channels.

Accessible Payments Adoption of common e-commerce and payment tech (PayPal, Apple Pay) signals readiness for direct-to-consumer or practice-buyer sales, enabling streamlined procurement experiences for clinics and patients.